As fellows and translational researchers/HCPs build their knowledge of the liver cancer speciality, you need to know which innovations are shaping primary liver cancer. Here are 6 of the key ones that will help you proficiently offer improved liver cancer treatment and patient care.

Knowing the effect of antiviral treatments on the natural history of HCC
Curative treatments
Understanding the when and how of using curative treatments (transplantation, resection and ablation) in the management of early HCC
Pathogenesis of HCC
A thorough understanding of the pathogenesis of hepatocellular carcinoma (HCC) and how best to translate this knowledge in clinical practice
Defining the role of pathology in HCC management
Knowing how radiology can help in the diagnosis of HCC and  assessing the radiological response of HCC
Assessing the evidence about SIRT and tyrosine kinase inhibitors in the treatment of advanced HCC

These topics also form the backbone of the forthcoming ILCA School of Liver Cancer. Originally planned to be held in Paris, France, we are now offering you the chance to join the expert faculty and fellow attendees remotely. Join us on 11-12 December for the first Virtual ILCA School and learn from the best! We have discounted tickets available for trainees, residents and ILCA Members.

Get Your Ticket Now

See the Full Programme

Meet the Experts